Roche cuts Genentech bid to $42.5 billion

ZURICH (Reuters) – Swiss drugmaker Roche Holding AG launched a hostile bid for Genentech on Friday and lowered its offer for the remaining 44 percent of the U.S. biotechnology company it does not already own. Roche is now offering $86.50 per share in

Leave a Reply